Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 12481 - 12500 out of 476768 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 15 mg tablet, 56 | Tablet 15 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 20 mg tablet, 56 | Tablet 20 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 20 mg tablet, 56 | Tablet 20 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01EJ01) ruxolitinib (adm: O) | Jakavi 5 mg tablet, 56 | Tablet 5 mg, 56 pcs | Retail price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders; Polycythemia Vera; Graft vs Host Disease | NovartisPharmaceuticalsAustraliaPtyLimited |
| Australia | (L01FA01) rituximab | Ruxience 100 mg/10 mL injection, 10 mL vial | Solution for I.V. infusion 100 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell; Arthritis, Rheumatoid; Microscopic Polyangiitis; Pemphigus | PfizerAustraliaPtyLtd |
| Australia | (L01FA01) rituximab | Truxima 100 mg/10 mL injection, 2 x 10 mL vials | Solution for I.V. infusion 100 mg in 10 mL, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Wegener Granulomatosis; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopic Polyangiitis | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L01FA01) rituximab | Ruxience 500 mg/50 mL injection, 50 mL vial | Solution for I.V. infusion 500 mg in 50 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Leukemia, Lymphocytic, Chronic, B-Cell; Arthritis, Rheumatoid; Microscopic Polyangiitis; Pemphigus | PfizerAustraliaPtyLtd |
| Australia | (L01FA01) rituximab | Truxima 500 mg/50 mL injection, 50 mL vial | Solution for I.V. infusion 500 mg in 50 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Wegener Granulomatosis; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopic Polyangiitis | CelltrionHealthcareAustraliaPtyLtd |
| Australia | (L01FC01) daratumumab | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FC01) daratumumab | Darzalex SC 1.8 g/15 mL injection, 15 mL vial | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Myeloma | Janssen-CilagPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01FY02) nivolumab and relatlimab | Opdualag injection, 20 mL vial | Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Melanoma | Bristol-MyersSquibbAustraliaPtyLtd |
| Australia | (L01XC02) rituximab | Riximyo 100 mg/10 mL injection, 2 x 10 mL vials | Solution for I.V. infusion 100 mg in 10 mL, 2 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Microscopic Polyangiitis; Wegener Granulomatosis | SandozPtyLtd |
| Australia | (L01XC02) rituximab | Riximyo 500 mg/50 mL injection, 50 mL vial | Solution for I.V. infusion 500 mg in 50 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin; Arthritis, Rheumatoid; Microscopic Polyangiitis; Wegener Granulomatosis | SandozPtyLtd |
| Australia | (L01XC03) trastuzumab | Herceptin SC 600 mg/5 mL injection, 5 mL vial | Solution for subcutaneous injection containing trastuzumab 600 mg in 5 mL, 1 pcs | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms; Breast Neoplasms | RocheProductsPtyLtd |
Pages
